Bausch Health eyes partial redemption of 6 1/8% note due 2025

Chicago, July 1 – Bausch Health Cos. Inc. announced that it plans to reduce its debt by $150 million through the redemption of that amount of 6 1/8% senior notes due 2025 (Cusips: 91831AAC5, C96729AC9), according to a press release.

The notes will be repurchased on Aug. 2 with cash generated from operations.

With this redemption, a total of $650 million in debt will have been redeemed by the company in 2021.

Based in Laval, Quebec, Bausch develops, manufactures and markets pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.